Emicizumab
Information about Emicizumab
Emicizumab Uses
Emicizumab is used in the treatment of haemophilia a.
How Emicizumab works
In people with hemophilia A who have low or missing factor VIII, the blood coagulation process cannot continue normally. Emicizumab acts like a bridge, bringing factor IXa and factor X together to allow the blood coagulation process to continue without needing to replace factor VIII.
Common side effects of Emicizumab
Injection site reactions (pain, swelling, redness), Joint pain, Headache
Available Medicine for Emicizumab
HemlibraRoche Products India Pvt Ltd
₹58900 to ₹2943924 variant(s)
Expert advice for Emicizumab
- Emicizumab is a prescription medicine used for preventing bleeding episodes in adults and children, ages newborn and older, with hemophilia A.
- Before using Emicizumab, tell your doctor about all of your medical conditions, including if you are pregnant, plan to become pregnant, are breastfeeding, or plan to breastfeed.
- Emicizumab increases the potential for your blood to clot. You must inform your doctor before taking any other medication.
- Your body may make antibodies against Emicizumab, which may stop Emicizumab from working properly. Contact your healthcare provider immediately if you notice that Emicizumab has stopped working (eg, increase in bleeds).